Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors

ChemMedChem. 2011 Jun 6;6(6):1011-6. doi: 10.1002/cmdc.201100077. Epub 2011 Apr 19.
No abstract available

MeSH terms

  • Administration, Oral
  • Animals
  • Diabetes Mellitus / drug therapy*
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacokinetics
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Hypoglycemic Agents / chemistry*
  • Hypoglycemic Agents / pharmacokinetics
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Models, Molecular
  • Protein Binding
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / metabolism
  • Rats
  • Rats, Wistar
  • Structure-Activity Relationship
  • Triazoles / chemistry*
  • Triazoles / pharmacokinetics
  • Triazoles / pharmacology
  • Triazoles / therapeutic use*

Substances

  • Enzyme Inhibitors
  • Hypoglycemic Agents
  • Triazoles
  • benzotriazole
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1